Spectral AI is on the brink of becoming a commercial-stage company, with the first sales of its DeepView wound imaging system due to start in its first market, the UK, later this year.
DeepView has been developed to take some of the guesswork out of handling serious second- and third-degree burns – to help physicians decide whether surgery is needed, for example – which at present often involves waiting to see if tissue regeneration starts to take place.
